1. Home
  2. PBHC vs LENZ Comparison

PBHC vs LENZ Comparison

Compare PBHC & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathfinder Bancorp Inc. (MD)

PBHC

Pathfinder Bancorp Inc. (MD)

N/A

Current Price

$16.96

Market Cap

108.9M

Sector

Finance

ML Signal

N/A

Logo LENZ Therapeutics Inc.

LENZ

LENZ Therapeutics Inc.

N/A

Current Price

$4.14

Market Cap

106.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PBHC
LENZ
Founded
1859
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.9M
106.8M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
PBHC
LENZ
Price
$16.96
$4.14
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $14.83
AVG Volume (30 Days)
2.5K
★ 1.2M
Earning Date
11-02-2026
10-28-2026
Dividend Yield
★ 2.40%
N/A
EPS Growth
★ 46.25
N/A
EPS
★ 0.47
N/A
Revenue
N/A
★ $19,088,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$125.50
P/E Ratio
$35.53
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.06
$2.80
52 Week High
$18.30
$32.13

Technical Indicators

Market Signals
Indicator
PBHC
LENZ
Relative Strength Index (RSI) 52.01 59.75
Support Level $16.71 $3.60
Resistance Level $17.05 $6.11
Average True Range (ATR) 0.17 0.39
MACD -0.01 0.14
Stochastic Oscillator 60.76 84.71

Price Performance

Historical Comparison
PBHC
LENZ

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

Share on Social Networks: